Cargando…

Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report

INTRODUCTION: Infliximab, an antibody against tumor necrosis factor alpha, is used to treat inflammatory bowel disease and has well-established efficacy and proven safety. Complications of this treatment are related to immunosuppression and include higher risk of serious infections and malignant neo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parra, Rogerio Serafim, Feitosa, Marley Ribeiro, Machado, Vanessa Foresto, Ramalho, Leandra Naira Zambelli, Rocha, Jose Joaquim Ribeiro da, Feres, Omar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627392/ https://www.ncbi.nlm.nih.gov/pubmed/26518665 http://dx.doi.org/10.1186/s13256-015-0730-5

Ejemplares similares

PPARG expression in colorectal cancer and its association with staging and clinical evolution (1)
por: Villa, Andre Luiz Prezotto, et al.
Publicado: (2020)

Rate of conversion to an open procedure: Is it really reduced in robotic colorectal surgery?
por: Parra, Rogério Serafim, et al.
Publicado: (2021)

Experimental Model of Rectal Carcinogenesis Induced by N-Methyl-N-Nitrosoguanidine in Mice with Endoscopic Evaluation
por: Machado, Vanessa Foresto, et al.
Publicado: (2020)

Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy
por: Parra, Rogério S., et al.
Publicado: (2018)

Surgical and postoperative evaluations of rectal adenomas excised with a rigid proctoscope
por: de Lima, Roberta Denise Alkmin Lopes, et al.
Publicado: (2020)

Retrospective analysis of surgical and oncological results of laparoscopic surgeries performed by residents of coloproctology
por: MOTA, BÁRBARA BIANCA LINHARES, et al.
Publicado: (2023)

Preservation of the superior rectal artery in laparoscopic colectomy for slow transit constipation: Is it really associated with better outcomes?
por: Parra, Rogério Serafim, et al.
Publicado: (2021)

Hyperbaric oxygen therapy decreases mortality due to Fournier’s gangrene: a retrospective comparative study
por: Féres, Omar, et al.
Publicado: (2021)

Spontaneous transvaginal small bowel evisceration: a case report
por: Parra, Rogério Serafim, et al.
Publicado: (2010)

Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases
por: Parra, Rogerio Serafim, et al.
Publicado: (2023)

COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil
por: Feitosa, Marley Ribeiro, et al.
Publicado: (2021)

Postoperative Complications and Stoma Rates After Laparoscopic Resection of Deep Infiltrating Endometriosis with Bowel Involvement
por: Parra, Rogério Serafim, et al.
Publicado: (2022)

Laparoscopic bowel resection of deep infiltrating endometriosis. Comparative outcomes of a public teaching hospital and a referral private hospital
por: Parra, Rogério Serafim, et al.
Publicado: (2020)

Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
por: Teixeira, Fabio Vieira, et al.
Publicado: (2019)

Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report
por: Garate, Ana Lorena Sousa de Vasconcelos, et al.
Publicado: (2021)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Successfully Treated Acute Fulminant Myocarditis Induced by Ulcerative Colitis with Extracorporeal Life Support and Infliximab
por: Kim, Han-Kyul, et al.
Publicado: (2016)

Fulminant organizing pneumonia in a patient with ulcerative colitis on mesalamine and infliximab: striving to identify the cause!
por: Gomes, Lídia, et al.
Publicado: (2023)

Preoperative rectal tumor embolization as an adjunctive tool for bloodless abdominoperineal excision: A case report
por: Feitosa, Marley Ribeiro, et al.
Publicado: (2020)

Familial adenomatous polyposis and desmoid tumors
por: Righetti, Ana Elisa Moraes, et al.
Publicado: (2011)

Neuroendocrine appendiceal tumor and endometriosis of the appendix: a case report
por: Parra, Rogério Serafim, et al.
Publicado: (2020)

Hyperbaric oxygen therapy ameliorates TNBS-induced acute distal colitis in rats
por: Parra, Rogério S, et al.
Publicado: (2015)

Melanoma of the anal canal
por: Parra, Rogerio Serafim, et al.
Publicado: (2010)

Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn's Disease: An Observational Study
por: Feitosa, Marley R., et al.
Publicado: (2021)

The Effect of Infliximab on Patients with Ulcerative Colitis in Korea
por: Seo, Hyun Il, et al.
Publicado: (2014)

Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab
por: Puthoor, Pamela R., et al.
Publicado: (2013)

An Antibiotic-Responsive Mouse Model of Fulminant Ulcerative Colitis
por: Kang, Silvia S, et al.
Publicado: (2008)

Infliximab: the evidence for its place in therapy in ulcerative colitis
por: Van Assche, Gert, et al.
Publicado: (2007)

Promising effect of infliximab on the extent of involvement in ulcerative colitis
por: Adibi, Peyman, et al.
Publicado: (2011)

Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update
por: Lawlor, Garrett, et al.
Publicado: (2009)

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
por: Fasanmade, Adedigbo A., et al.
Publicado: (2009)

Pericardial Effusion due to Infliximab Therapy for Ulcerative Colitis
por: Mirza, Muhammad, et al.
Publicado: (2018)

Early Serum Infliximab Levels in Pediatric Ulcerative Colitis
por: deBruyn, Jennifer C. C., et al.
Publicado: (2021)

A Novel Severity Score Index for Febrile Neutropenic Patients with Colorectal Diseases
por: Perazzoli, Camila, et al.
Publicado: (2019)

Leukocytoclastic Vasculitis Secondary to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Diseases: A Multicenter Retrospective Cohort Study
por: Parra, Rogério Serafim, et al.
Publicado: (2023)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
por: Xie, Feng, et al.
Publicado: (2009)

Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis
por: Mir, Fazia A., et al.
Publicado: (2018)

Listeria Meningitis during Infliximab-based Treatment for Ulcerative Colitis
por: Tsuchiya, Atsunori, et al.
Publicado: (2018)

Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
por: Kim, Eun Soo
Publicado: (2021)

Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis
por: Sablich, Renato, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_caj9irme4s7r9l2aoi6h02ppbu